Is Danaher (DHR) a Buy, Hold, or Sell in 2025?
AI-powered insights updated on 8/29/2025.
AI Signal: HOLD
Danaher (DHR) faces mixed momentum, with recent price declines and weakening bullish signals offset by solid biotechnology performance and raised EPS guidance. Investors should monitor key support levels amid potential downside risk.
Price Below 21-day E M A
Indicates short-term weakness
Biotechnology Segment Growth
6% core revenue increase
Raised E P S Guidance
Full-year adjusted diluted net EPS raised to $7.70-$7.80
Full Analysis Breakdown
Expand the sections below for a detailed look at our analysis.
Go Beyond the Analysis
Get real-time insights, compare stocks, and chat with our AI analyst on the interactive dashboard.
Disclaimer
The information provided on this page is for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice and you should not treat any of the page's content as such. ProfitScout does not recommend that any cryptocurrency should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions.